Related Experiment Video
Updated: Mar 23, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by
Tianyuan Xu1, Liang Qin1, Zhaowei Zhu2
1Department of Urology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Abstract:
Urothelial bladder cancer (UBC) is a common genitourinary malignancy. MiR-31, a well-identified miRNA, exhibits diverse properties in different cancers. However, the specific functions and mechanisms of miR-31 in UBC have not been investigated. In this study, tumor samples, especially invasive UBC, showed significantly reduced level of miR-31, as compared with normal urothelium. Prognostic analysis using the EORTC model showed that down-regulation of miR-31 correlated with higher risks of recurrence and progression in noninvasive UBC cases. Remarkably, overexpression of miR-31 mimics in UBC cell lines inhibited cell proliferation, migration and invasion. Integrin α5 (ITGA5), an integrin family member, was subsequently identified as a direct target of miR-31 in UBC cells. When treated with mitomycin-C (MMC), miR-31-expressing UBC cells displayed lower survival and higher apoptotic rates, and deactivated Akt and ERK. These effects arising from miR-31 overexpression were abrogated by ITGA5 restoration. Furthermore, miR-31 markedly inhibited tumor growth and increased the effectiveness of MMC in UBC xenografts. In summary, our data suggest that miR-31 is a prognostic predictor and can serve as a potential therapeutic target of UBC.
Insights
MicroRNA-31 (miR-31) is significantly reduced in urothelial bladder cancer (UBC), correlating with higher recurrence risks. Restoring miR-31 inhibits UBC progression and enhances chemotherapy effectiveness, suggesting its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Urothelial bladder cancer (UBC) is a prevalent genitourinary malignancy with diverse clinical behaviors.
- MicroRNAs (miRNAs) play crucial roles in cancer, but the specific function of miR-31 in UBC remains unclear.
- Understanding miR-31's role is vital for developing novel diagnostic and therapeutic strategies for UBC.
Purpose of the Study:
- To investigate the role and mechanism of miR-31 in urothelial bladder cancer.
- To determine if miR-31 levels correlate with UBC prognosis and clinical outcomes.
- To explore the therapeutic potential of miR-31 in UBC treatment.
Main Methods:
- Quantitative analysis of miR-31 expression in UBC tumor samples and normal urothelium.
- Prognostic analysis using the EORTC model to assess the correlation between miR-31 levels and UBC recurrence/progression.
- In vitro studies involving miR-31 mimic transfection in UBC cell lines to evaluate effects on proliferation, migration, and invasion.
- Identification of miR-31 direct targets using bioinformatics and experimental validation.
- In vivo studies using UBC xenografts to assess the impact of miR-31 on tumor growth and chemotherapy response.
Main Results:
- Down-regulation of miR-31 was observed in UBC tissues, particularly in invasive cases, compared to normal urothelium.
- Reduced miR-31 levels significantly correlated with increased risks of recurrence and progression in noninvasive UBC.
- Overexpression of miR-31 suppressed UBC cell proliferation, migration, and invasion by targeting Integrin α5 (ITGA5).
- miR-31 overexpression enhanced sensitivity to mitomycin-C (MMC) by promoting apoptosis and deactivating Akt/ERK signaling, effects reversed by ITGA5 restoration.
- In vivo, miR-31 inhibited tumor growth and potentiated MMC efficacy in UBC xenografts.
Conclusions:
- miR-31 acts as a tumor suppressor in urothelial bladder cancer.
- Down-regulation of miR-31 is a significant prognostic predictor for UBC recurrence and progression.
- miR-31 represents a promising therapeutic target for enhancing conventional chemotherapy in UBC.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

